Cholelithiasis obstructive – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Mon, 03 Aug 2026 10:43:40 +0000 en-US hourly 1 https://wordpress.org/?v=7.1 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Cholelithiasis obstructive – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 A study to evaluate if atorvastatin prevents gallstones in patients undergoing bariatric surgery https://clinicaltrials.eu/trial/a-study-to-evaluate-if-atorvastatin-prevents-gallstones-in-patients-undergoing-bariatric-surgery/ Mon, 03 Aug 2026 10:43:40 +0000 https://clinicaltrials.eu/trial/a-study-to-evaluate-if-atorvastatin-prevents-gallstones-in-patients-undergoing-bariatric-surgery/ This study focuses on the prevention of gallstones, which are hard deposits that can form in the gallbladder, in people who have undergone bariatric surgery, a procedure used for significant weight loss. The purpose of the study is to evaluate whether the medication atorvastatin can help prevent these stones from forming. This medication is an oral drug used to lower cholesterol, a fatty substance found in the blood.

Participants in the study will receive either atorvastatin or standard care. If atorvastatin is used, it is taken once daily, starting two weeks before the surgery and continuing for six months afterward. The study will monitor changes in LDL-cholesterol, which is often referred to as bad cholesterol, as well as levels of bile acids, which are substances produced by the liver to help digest fats. The process includes monitoring for any side effects related to the medication during the period following the surgery.

]]>